Theranica, a neuromodulation therapeutics company advancing clinically validated, drug-free treatments for idiopathic pain conditions and setting a new standard of care in migraine with REN-based ...
The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Sept. 24, 2025 /PRNewswire/ --The Digital Migraine Treatment Devices Market is witnessing ...
Pair of projects in Greater Cincinnati to create nearly 500 jobs, over $29M investment State officials say eight approved development projects are expected to bring 1,320 new jobs and more than $853 ...
Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief and 36% (9/25) reported consistent freedom from headache. The Food and Drug Administration (FDA) has ...
SAN DIEGO -- An investigational device that delivered conditioned room air intranasally treated acute migraine attacks without drugs, a randomized sham-controlled study showed. Compared with sham, ...
A device that is a noninvasive, drug-free way to treat and prevent migraine headaches is now FDA-approved for use in children. Millions of people suffer from migraine headaches that can be ...
SAN DIEGO — Neuromodulation of the sphenopalatine ganglion (SPG) through transnasal evaporative cooling is a promising nonpharmacologic treatment for acute migraine, results of a randomized controlled ...
DARIEN, Conn., May 13, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology will be conducting live demonstrations of its clinically proven neuromodulation treatment for migraine at Booth 102 ...
Migraines can be debilitating and are notoriously hard to treat. Dr. Giancarlo Barolat has seen it first-hand over the past 25 years. Dr. Giancarlo Barolat, Director of Barolat Neuroscience at ...
Published in the Journal of Clinical Medicine, the study demonstrates that administering treatment of migraine with Remote Electrical Neuromodulation (REN) does not impact blood s ...
Nerivio is a wireless remote electrical neuromodulation device that is self-applied to the upper arm. Among pediatric patients with available data, 72.2% (13/18) reported consistent headache relief ...